TY  - CHAP
M1  - Book, Section
TI  - Pancreatic Cancer
A1  - Von Hoff, Daniel D.
A2  - Jameson, J. Larry
A2  - Fauci, Anthony S.
A2  - Kasper, Dennis L.
A2  - Hauser, Stephen L.
A2  - Longo, Dan L.
A2  - Loscalzo, Joseph
PY  - 2018
T2  - Harrison's Principles of Internal Medicine, 20e
AB  - Pancreatic  cancer  is  the  third  leading  cause  of  death  from  cancer  in  the  United  States  with  >53,000  Americans  diagnosed  and  >43,000  dying  from  the  disease  each  year.  Unfortunately,  pancreatic  cancer  is  projected  to  be  the  second  leading  cause  of  death  from  cancer  in  the  United  States  by  2030.  Worldwide  pancreatic  cancer  is  the  eleventh  most  common  cancer  with  338,000  new  patients  diagnosed  and  >334,000  deaths  (seventh  cause  of  cancer  deaths).  Pancreatic  cancer  currently  has  the  worst  survival  rate  of  any  cancer  with  an  overall  5-year  survival  (regardless  of  stage)  of  ~8.2%.  However,  that  situation  is  changing  because  some  advances  have  been  made  against  the  disease  with  some  improvements  in  survival  (see  below)  that  may  affect  the  5-year  survival  statistics.  In  particular,  knowledge  about  specific  molecular  subsets  of  the  disease  has  become  crucial  so  that  one  can  provide  the  best  possible  care  for  their  patients  with  pancreatic  cancer.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1159152794
ER  -